Blue Water Life Science Advisors’s 10x Genomics TXG Stock Holding History

Blue Water Life Science Advisors’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.6M	Sell	642,000 -448,000	-41%	-$11.7M	15.5%	2
2026 Q1	$23.1M	Buy	+1,090,000	New	+$21.8M	18.56%	1
2025 Q3	–	Sell	-1,100,720	Closed	-$12.7M	–	9
2025 Q2	$12.7M	Buy	+1,100,720	New	+$10M	10.09%	5
2024 Q3	–	Sell	-230,000	Closed	-$4.47M	–	10
2024 Q2	$4.47M	Buy	230,000 +35,500	+18%	+$930K	4.35%	5
2024 Q1	$7.3M	Hold	194,500	–	–	6.87%	4
2023 Q4	$10.9M	Buy	+194,500	New	+$8.46M	9.53%	5
2022 Q2	–	Sell	-211,917	Closed	-$16.1M	–	12
2022 Q1	$16.1M	Buy	+211,917	New	+$18.5M	7.65%	6

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Blue Water Life Science Advisors's TXG Position: Q2 2026 in Review

Blue Water Life Science Advisors reduced its 10x Genomics (TXG) stake by 41% in Q2 2026, selling an estimated $11.7M and leaving 642,000 shares worth $24.6M. The position accounts for 15.5% of the portfolio, ranked #2.

Blue Water Life Science Advisors first reported a position in TXG in Q1 2022 and has held it in 7 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Blue Water Life Science Advisors held 642,000 shares of 10x Genomics worth $24.6M as of Q2 2026.
Blue Water Life Science Advisors sold 448,000 10x Genomics shares in Q2 2026, an estimated $11.7M.
10x Genomics made up 15.5% of Blue Water Life Science Advisors's portfolio in Q2 2026, its #2 holding.
Blue Water Life Science Advisors first reported a position in 10x Genomics in Q1 2022 and has held it in 7 quarters since.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.